Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -57.76x is 99% above its 5-year average of -7641.03x, near the high end of its 5-year range (-26794.00x–-22.70x).
38.47% below its 12-month average of -41.71x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -23.91x.
INTEREST COVERAGE RATIO
-57.76x
INTEREST COVERAGE RATIO AVG TTM
-41.71x
INTEREST COVERAGE RATIO AVG 3Y
-10088.36x
INTEREST COVERAGE RATIO AVG 5Y
-7641.03x
INTEREST COVERAGE RATIO AVG 10Y
-3585.81x
INTEREST COVERAGE RATIO AVG 15Y
-1570.52x
INTEREST COVERAGE RATIO AVG 20Y
-834.56x
CURRENT VS TTM AVG
-38.47%
CURRENT VS 3Y AVG
+99.43%
CURRENT VS 5Y AVG
+99.24%
CURRENT VS 10Y AVG
+98.39%
CURRENT VS 15Y AVG
+96.32%
CURRENT VS 20Y AVG
+93.08%
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 323 covered companies
CURRENT VS SECTOR MEDIAN
-1275.24%
vs the sector median at left
Altimmune, Inc.
Market Cap
$519.25M
Interest Coverage Ratio
-57.76x
TTM Avg
-41.71x
3Y Avg
-10088.36x
5Y Avg
-7641.03x
Market Cap
$517.79M
Interest Coverage Ratio
-69.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$517.73M
Interest Coverage Ratio
-192.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$491.55M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$547.86M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$551.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$487.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | $519.25M | -57.76x | -41.71x | -10088.36x | -7641.03x |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | -69.85x | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | -192.50x | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $491.93M | -1.91x | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | -17.61x | 2.56x | 1.47x | 1.63x |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | N/A | N/A | N/A | N/A |
Interest Coverage
-57.8x
Debt/Equity
0.08
Current Ratio
26.78
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -23.91x |
| 2026-03-31 | -22.70x |
| 2025-12-31 | -32.98x |
| 2025-09-30 | -42.14x |
| 2025-06-30 | -86.83x |
| 2025-03-31 | -21815.00x |
| 2024-12-31 | -24866.00x |
| 2024-09-30 | -4127.83x |
| 2024-06-30 | -26745.00x |
| 2024-03-31 | -26794.00x |
| 2023-12-31 | -16811.50x |
| 2023-09-30 | -777.24x |
| 2023-06-30 | -9003.50x |
| 2023-03-31 | -10879.50x |
| 2022-09-30 | -386.75x |
| 2022-06-30 | -313.77x |
| 2022-03-31 | -314.50x |
| 2021-09-30 | -1006.18x |
| 2021-06-30 | -1130.18x |
| 2021-03-31 | -1238.42x |
| 2020-12-31 | -5504.25x |
| 2020-09-30 | -8054.60x |
| 2020-06-30 | -5567.71x |
| 2020-03-31 | -3876.26x |
| 2019-09-30 | -14911.88x |
| 2019-06-30 | -4747.17x |
| 2019-03-31 | -3146.70x |
| 2018-12-31 | -214.73x |
| 2018-09-30 | -24.31x |
| 2018-06-30 | -2829.67x |
| 2018-03-31 | -6890.30x |
| 2017-12-31 | -6171.20x |
| 2017-09-30 | -13204.94x |
| 2017-06-30 | -41.29x |
| 2017-03-31 | -52.53x |
| 2016-12-31 | 0.00x |
| 2016-09-30 | -424.08x |
| 2016-06-30 | -57.88x |
| 2016-03-31 | -1194.70x |
| 2015-12-31 | -154.45x |
| 2015-09-30 | -167.73x |
| 2015-06-30 | -147.97x |
| 2015-03-31 | 45.85x |
| 2014-12-31 | -72.17x |
| 2014-09-30 | -85.13x |
| 2014-06-30 | -20.44x |
| 2014-03-31 | -34.38x |
| 2013-12-31 | -63.63x |
| 2013-09-30 | -35.62x |
| 2013-06-30 | -14.81x |
| 2013-03-31 | -10.93x |
| 2012-12-31 | -12.34x |
| 2012-09-30 | -15.91x |
| 2012-06-30 | -13.10x |
| 2012-03-31 | -525.33x |
| 2011-12-31 | -77.14x |
| 2011-09-30 | -304.26x |
| 2011-06-30 | -203.08x |
| 2011-03-31 | -294.13x |
| 2010-12-31 | -2.32x |
| 2010-09-30 | -3.56x |
| 2010-06-30 | -6.01x |
| 2010-03-31 | -7.81x |
| 2009-12-31 | -6.81x |
| 2009-09-30 | -10.05x |
| 2009-06-30 | -11.31x |
| 2009-03-31 | -9.15x |
| 2008-12-31 | -7.62x |
| 2008-09-30 | -6.32x |
| 2008-06-30 | -33.12x |
| 2008-03-31 | -7.36x |
| 2007-12-31 | -7.03x |
| 2007-09-30 | -6.12x |
